U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541196) titled 'PAW-Hydrogel for Chronic Wound Healing' on April 14.
Brief Summary: The goal of this randomized controlled trial is to evaluate the efficacy and safety of a novel hydrogel made of Carbopol(R) 940 functionalized with Plasma-Activated Water (PAW) in patients with chronic wounds (diabetic foot ulcers, pressure injuries, dehiscent wounds, arterial and venous ulcers). The main questions it aims to answer are:
* Does PAW-hydrogel accelerate wound closure (reduction in surface area) compared to standard advanced wound care?
* Does PAW-hydrogel reduce bacterial load in the wound bed?
* Is PAW-hydrogel safe and well-tolerated (local adve...